These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11032353)

  • 1. Effects of anaemia on cardiovascular status.
    O'Riordan E; Foley RN
    Nephrol Dial Transplant; 2000; 15 Suppl 3():19-22. PubMed ID: 11032353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular consequences of renal anaemia and erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 1999 May; 14(5):1317-23. PubMed ID: 10344393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaemia, renal insufficiency and cardiovascular outcome.
    Hegarty J; Foley RN
    Nephrol Dial Transplant; 2001; 16 Suppl 1():102-4. PubMed ID: 11369834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and risk factors for left ventricular disorders in chronic uraemia.
    Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray DC; Barre PE
    Nephrol Dial Transplant; 1996 Jul; 11(7):1277-85. PubMed ID: 8672023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia in chronic renal disease: lessons learned since Seville 1994.
    Parfrey P
    Nephrol Dial Transplant; 2001; 16 Suppl 7():41-5. PubMed ID: 11590256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaemia management and cardiomyopathy in renal failure.
    Donne RL; Foley RN
    Nephrol Dial Transplant; 2002; 17 Suppl 1():37-40. PubMed ID: 11812910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of cardiovascular damage in the early renal population.
    London G
    Nephrol Dial Transplant; 2001; 16 Suppl 2():3-6. PubMed ID: 11369841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the short-term and long-term consequences of anaemia in CRF patients?
    Mann JF
    Nephrol Dial Transplant; 1999; 14 Suppl 2():29-36. PubMed ID: 10334665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of anaemia: focus on the heart and blood vessels.
    Metivier F; Marchais SJ; Guerin AP; Pannier B; London GM
    Nephrol Dial Transplant; 2000; 15 Suppl 3():14-8. PubMed ID: 11032352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of haemoglobin: why not?
    Jacobs C
    Nephrol Dial Transplant; 1999; 14 Suppl 2():75-9. PubMed ID: 10334671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing a fateful alliance: anaemia and cardiovascular outcomes.
    Eckardt KU
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi16-20. PubMed ID: 15958821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher target haemoglobin level and early anaemia treatment: different or complementary concepts?
    Macdougall LC
    Nephrol Dial Transplant; 2000; 15 Suppl 3():3-7. PubMed ID: 11032350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CREATE trial--building the evidence.
    Eckardt KU;
    Nephrol Dial Transplant; 2001; 16 Suppl 2():16-8. PubMed ID: 11369844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of anaemia and kidney function in congestive heart failure and preserved systolic function.
    Philipp S; Ollmann H; Schink T; Dietz R; Luft FC; Willenbrock R
    Nephrol Dial Transplant; 2005 May; 20(5):915-9. PubMed ID: 15741202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of intervention in early renal disease.
    Portolés J
    Nephrol Dial Transplant; 2001; 16 Suppl 2():12-5. PubMed ID: 11369843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should hemoglobin be normalized in uremic patients?
    Foley RN
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S58-61. PubMed ID: 12227728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for cardiac morbidity and mortality in dialysis patients.
    Foley RN; Parfrey PS
    Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):608-14. PubMed ID: 7881984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels.
    Roberts TL; Foley RN; Weinhandl ED; Gilbertson DT; Collins AJ
    Nephrol Dial Transplant; 2006 Jun; 21(6):1652-62. PubMed ID: 16449283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal haemoglobin during treatment with recombinant human erythropoietin.
    Ritz E; Amann K
    Nephrol Dial Transplant; 1998; 13 Suppl 2():16-22. PubMed ID: 9566486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cardiovascular damage in early renal disease.
    Levin A
    Nephrol Dial Transplant; 2001; 16 Suppl 2():7-11. PubMed ID: 11369842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.